Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.57 AUD | -2.80% | +1.32% | -8.94% |
03-14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
03-14 | Morgans Financial Upgrades Clinuvel Pharmaceuticals to Add From Hold; Price Target is AU$16 | MT |
Sales 2024 * | 89.47M 58.44M 79.82M | Sales 2025 * | 98.61M 64.41M 87.97M | Capitalization | 730M 477M 651M |
---|---|---|---|---|---|
Net income 2024 * | 34M 22.21M 30.33M | Net income 2025 * | 37M 24.17M 33.01M | EV / Sales 2024 * | 6.07 x |
Net cash position 2024 * | 187M 122M 167M | Net cash position 2025 * | 219M 143M 196M | EV / Sales 2025 * | 5.18 x |
P/E ratio 2024 * |
21.3
x | P/E ratio 2025 * |
19.7
x | Employees | - |
Yield 2024 * |
0.46% | Yield 2025 * |
0.51% | Free-Float | 79.56% |
Latest transcript on Clinuvel Pharmaceuticals Limited
1 day | -2.80% | ||
1 week | +1.32% | ||
Current month | +1.46% | ||
1 month | +5.96% | ||
3 months | -6.90% | ||
6 months | -4.96% | ||
Current year | -8.94% |
Managers | Title | Age | Since |
---|---|---|---|
Philippe Wolgen
CEO | Chief Executive Officer | 61 | 05-10-31 |
Darren M. Keamy
DFI | Director of Finance/CFO | - | 05-10-31 |
Lachlan Hay
COO | Chief Operating Officer | - | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Philippe Wolgen
CEO | Chief Executive Officer | 61 | 05-10-31 |
Director/Board Member | - | 07-02-05 | |
Karen Agersborg
BRD | Director/Board Member | - | 18-01-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 14.57 | -2.80% | 54,613 |
24-04-24 | 14.99 | +0.67% | 106,329 |
24-04-23 | 14.89 | +4.49% | 75,814 |
24-04-22 | 14.25 | -0.90% | 122,966 |
24-04-19 | 14.38 | -5.95% | 254,065 |
Delayed Quote Australian S.E., April 26, 2024 at 02:10 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.94% | 476M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
-9.14% | 11.95B | |
+5.24% | 8.71B | |
-8.42% | 8.12B |
- Stock Market
- Equities
- CUV Stock